CERo Therapeutics (NASDAQ:CERO) Cut to “Hold” at D Boral Capital
CERo Therapeutics (NASDAQ:CERO – Get Free Report) was downgraded by equities research analysts at D Boral Capital from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Friday,Zacks.com reports. CERO has been the subject of a number of other reports. D. Boral Capital reiterated a “hold” rating on shares […]
CERo Therapeutics (NASDAQ:CERO – Get Free Report) was downgraded by equities research analysts at D Boral Capital from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Friday,Zacks.com reports. CERO has been the subject of a number of other reports. D. Boral Capital reiterated a “hold” rating on shares […]
